Health-related quality of life outcomes for patients with immune thrombocytopenic purpura

Annals of Hematology

Volumn 89, Issue SUPPL. 1, 2010, Pages

  Klaassen, Robert J ^a   Young, Nancy L ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b LAURENTIAN UNIVERSITY   (Canada)

Author keywords

Idiopathic; Outcome measures; Purpura; Quality of life; Thrombocytopenic

Indexed keywords

IMMUNOGLOBULIN; PREDNISONE; RHESUS D ANTIBODY;

BLEEDING; CLINICAL RESEARCH; DISEASE SEVERITY; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; PROCEDURES; PSYCHOLOGY;

HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUALITY OF LIFE;

EID: 77955660902     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0981-6     Document Type: Review

References (26)

1. Abrahamson PE, Hall SA, Feudjo-Tepie M, Mitrani-Gold FS, Logie J (2010) The incidence of idiopathic thrombocytopenic purpura (ITP) among adults: a population-based study and literature review. Eur J Haematol (in press)
2. B Zeller J Helgestad M Hellebostad S Kolmannskog T Nystad K Stensvold, et al. 2000 Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration Paediatr Hem Onc 17 551 558 10.1080/ 08880010050122816 1:STN:280:DC%2BD3cvos1SmtA%3D%3D
3. T Kuhne P Imbach PH Bolton-Maggs W Berchtold V Blanchette GR Buchanan, et al. 2001 Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study Lancet 358 2122 2125 10.1016/S0140-6736(01)07219-1 1:STN:280:DC%2BD38%2FlslKlug%3D%3D 11784627
4. T Kuhne GR Buchanan S Zimmerman LA Michaels R Kohan W Berchtold, et al. 2003 A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group J Pediatr 143 605 608 10.1067/S0022-3476(03)00535-3 14615730
5. JS Lilleyman 1994 Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology Arch Dis Child 71 251 253 10.1136/adc.71.3.251 1:STN:280:DyaK2M%2FntVaksw%3D%3D 7979501
6. CE Neunert GR Buchanan P Imbach PH Bolton-Maggs CM Bennett EJ Neufeld, et al. 2008 Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura Blood 112 4003 4008 10.1182/blood-2008-03-138487 1:CAS:528:DC%2BD1cXhsVSmsr3N 18698007
7. JE Portielje RG Westendorp HC Kluin-Nelemans A Brand 2001 Morbidity and mortality in adults with idiopathic thrombocytopenic purpura Blood 97 2549 2554 10.1182/blood.V97.9.2549 1:CAS:528:DC%2BD3MXjtlSitLk%3D 11313240
8. PH Bolton-Maggs I Moon 1997 Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines [see comments] Lancet 350 620 623 10.1016/S0140-6736(97)04143-3 1:STN:280:DyaK2svjsVWmug%3D%3D 9288044
9. YC Cohen B Djulbegovic O Shamai-Lubovitz B Mozes 2000 The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts Arch Intern Med 160 1630 1638 10.1001/archinte.160.11.1630 1:STN:280:DC%2BD3czgtlyluw%3D%3D 10847256
10. V Blanchette P Imbach M Andrew M Adams J McMillan E Wang, et al. 1994 Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura [see comments] Lancet 344 703 707 10.1016/S0140-6736(94)92205-5 1:STN:280:DyaK2czlvFeisg%3D%3D 7915773
11. VS Blanchette B Luke M Andrew S Sommerville-Nielsen D Barnard B de Veber, et al. 1993 A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura [see comments] J Pediatr 123 989 995 10.1016/S0022-3476(05)80400-7 1:STN:280:DyaK2c%2Fks1aktA%3D%3D 8229536
12. MH Boyle W Furlong D Feeny GW Torrance J Hatcher 1995 Reliability of the Health Utilities Index-Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire Qual Life Res 4 249 257 10.1007/BF02260864 1:STN:280:DyaK2MzjvVWquw%3D%3D 7613535
13. H Raat AM Botterweck JM Landgraf WC Hoogeveen ML Essink-Bot 2005 Reliability and validity of the short form of the child health questionnaire for parents (CHQ-PF28) in large random school based and general population samples J Epidemiol Commun Health 59 75 82 10.1136/jech.2003.012914
14. JW Varni TM Burwinkle M Seid D Skarr 2003 The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity Ambul Pediatr 3 329 341 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2 14616041
15. WHO Quality of Life Group 1993 Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL) Qual Life Res 2 153 159 10.1007/BF00435734
16. WHO Quality of Life Group 1995 The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization Soc Sci Med 41 1403 1409 10.1016/0277-9536(95)00112-K
17. C Eiser M Jenney 2007 Measuring quality of life Arch Dis Child 92 348 350 10.1136/adc.2005.086405 17376942
18. C Eiser 2004 Use of quality of life measures in clinical trials Ambul Pediatr 4 395 399 10.1367/A03-112R.1 15264945
19. RJ Klaassen VS Blanchette D Barnard CD Wakefield C Curtis CS Bradley, et al. 2007 Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools J Pediatr 150 510 515 10.1016/j.jpeds.2007.01.037 17452226
20. Z Zhou L Yang Z Chen X Chen Y Guo X Wang, et al. 2007 Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China Eur J Haematol 78 518 523 10.1111/j.1600-0609.2007.00844.x 17419740
21. CF Snyder SD Mathias D Cella JJ Isitt AW Wu J Young 2008 Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey Curr Med Res Opin 24 2767 2776 10.1185/03007990802377461 18715526
22. JW Varni CA Limbers TM Burwinkle 2007 How young can children reliably and validly self-report their health-related quality of life?: an analysis of 8, 591 children across age subgroups with the PedsQL 4.0 Generic Core Scales Health Qual Life Outcomes 5 1 10.1186/1477-7525-5-1 17201920
23. SD Mathias JB Bussel JN George R McMillan GJ Okano JL Nichol 2007 A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation Health Qual Life Outcomes 5 11 10.1186/1477-7525-5-11 17316442
24. S von Mackensen C Nilsson M Jankovic N Mirra E D'Angelo A Borkhardt, et al. 2006 Development of a disease-specific quality of life questionnaire for children & adolescents with idiopathic thrombocytopenic purpura (ITP-QoL) Pediatr Blood Cancer 47 688 691 10.1002/pbc.20977
25. JN George SD Mathias RS Go M Guo DH Henry R Lyons, et al. 2009 Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials Br J Haematol 144 409 415 10.1111/j.1365-2141.2008.07464.x 1:CAS:528: DC%2BD1MXis1Wrsbg%3D 19016720
26. Varni JW. The PedsQL Measurement Model for the Pediatric Quality of Life Inventory. http://www.pedsql.org